Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorShantou Central Hospital
About this trial
This study aims to explore the effectiveness of early intervention of airwave compression therapy to prevent the occurrence of postoperative breast cancer-related lymphedema(BCRL).
Eligibility criteria
Qualifiers
Volunteer to participate in this clinical trial. Fully understand and be informed about the study and sign an informed consent form (ICF). Willing to follow and able to complete all test procedures;
Female, ≥18 years old and ≤70 years old at the time of signing the ICF;
Patients with unilateral breast cancer diagnosed by histopathology or cytology;
No distant metastasis;
Disqualifiers
Breast malignancy derived from other tumors rather than the primary breast cancer;
Patients with second primary tumor;
Contraindication to airwave compression therapy: Acute venous thrombosis; Acute inflammatory skin disease; Erysipelas; Arrhythmia; Pulmonary edema; Unstable hypertension; People with artificial pacemakers; Deep thrombophlebitis;
Have a history of mental illness or other reasons can not cooperate with treatment;
Trial design
Treatments tested in this trial
- airwave compression therapy
- standard care: health education and routine functional exercise
Treatment groups
132 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov